Treatment with pembrolizumab in combination with the oncolytic virus pelareorep promotes anti-tumor immunity in patients with advanced pancreatic adenocarcinoma

Mahalingam D et al. Previously presented at the 2021 ASCO Annual Meeting
Download PDF
View Resource